151 related articles for article (PubMed ID: 6895353)
21. Hemiaplasia of the thyroid with thyrotoxicosis.
Mortimer PS; Tomlinson IW; Rosenthal FD
J Clin Endocrinol Metab; 1981 Jan; 52(1):152-5. PubMed ID: 7451642
[TBL] [Abstract][Full Text] [Related]
22. A stable, reproducible radioreceptorassay for thyrotropin binding inhibiting immunoglobulins (TBII).
Bliddal H
Scand J Clin Lab Invest; 1981 Sep; 41(5):441-9. PubMed ID: 6118939
[TBL] [Abstract][Full Text] [Related]
23. [Evolution of immunoglobulins IgA, IgM, IgG and LATS during treatment of hyperthyroidism with carmibazole and radioiodine].
Mahaux JE; Delcourt R; Nagel M; Chamla-Soumenkoff J; Levin S
Ann Endocrinol (Paris); 1970; 31(2):314-23. PubMed ID: 4192759
[No Abstract] [Full Text] [Related]
24. Thyrotrophin binding inhibiting immunoglobulins in Graves' disease before, during and after antithyroid therapy, and its relation to long-acting thyroid stimulator.
Docter R; Bos G; Visser TJ; Hennemann G
Clin Endocrinol (Oxf); 1980 Feb; 12(2):143-53. PubMed ID: 6105023
[TBL] [Abstract][Full Text] [Related]
25. Toxic multinodular goiter: a variant of autoimmune hyperthyroidism.
Kraiem Z; Glaser B; Yigla M; Pauker J; Sadeh O; Sheinfeld M
J Clin Endocrinol Metab; 1987 Oct; 65(4):659-64. PubMed ID: 2888784
[TBL] [Abstract][Full Text] [Related]
26. Studies on the antigen reacting with the thyroid-stimulating immunoglobulin (LATS) in thyrotoxicosis.
Benhamou-Glynn N; el-Kabir DJ; Roitt IM; Doniach D
Immunology; 1969 Feb; 16(2):187-204. PubMed ID: 4181510
[TBL] [Abstract][Full Text] [Related]
27. Comparison of thyroid antigens by the experimental production of precipitating antibodies to human thyroid fractions and the identification of an antibody which competes with long-acting thyroid stimulator (LATS) for thyroid binding.
von Westarp C; Knox AJ; Row VV; Volpé R
Acta Endocrinol (Copenh); 1977 Apr; 84(4):759-67. PubMed ID: 576759
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis of Graves' ophthalmopathy without hyperthyroidism: long-acting thyroid stimulator (LATS) determination as laboratory adjunct.
Gharib H; Mayberry WE
Mayo Clin Proc; 1970 Jun; 45(6):444-9. PubMed ID: 4193249
[No Abstract] [Full Text] [Related]
29. Evidence that both long-acting thyroid stimulator and long-acting thyroid stimulator-protector stimulate the human thyroid gland.
Holmes SD; Dirmikis SM; Martin TJ; Munro DS
J Endocrinol; 1979 Feb; 80(2):215-21. PubMed ID: 220366
[TBL] [Abstract][Full Text] [Related]
30. LATS in Graves' disease.
McKenzie JM; Zakarija M
Recent Prog Horm Res; 1976; 33():29-57. PubMed ID: 198858
[No Abstract] [Full Text] [Related]
31. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
32. Dissociation of serum LATS activity and hyperfunction and autonomy of the thyroid gland in Graves' disease.
Hennemann G; Dolman A; Docter R; De Reus A; Van Zijl J
J Clin Endocrinol Metab; 1975 Jun; 40(6):935-41. PubMed ID: 1173367
[TBL] [Abstract][Full Text] [Related]
33. Relation between thyroid function and serum levels of long-acting thyroid stimulator.
Davis JC; Hipkin LJ; Summers VK; Gimlette TM
Acta Endocrinol (Copenh); 1975 Jul; 79(3):451-8. PubMed ID: 1173501
[TBL] [Abstract][Full Text] [Related]
34. Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease.
Zakarija M; McKenzie JM; Munro DS
J Clin Invest; 1983 Oct; 72(4):1352-6. PubMed ID: 6138363
[TBL] [Abstract][Full Text] [Related]
35. Direct evidence for human thyroidal stimulation by LATS-protector.
Shishiba Y; Shimizu T; Yoshimura S; Shizume K
J Clin Endocrinol Metab; 1973 Mar; 36(3):517-21. PubMed ID: 4739312
[No Abstract] [Full Text] [Related]
36. [Relation between Basedow's disease and Hashimoto thyroiditis].
Földes J; Takó J; Bános C; Gesztesi E; Juhász J
Endokrinologie; 1971 Apr; 57(3):329-37. PubMed ID: 5108742
[No Abstract] [Full Text] [Related]
37. LATS and Graves' disease.
Soloman DH; Chopra IJ
Calif Med; 1970 Aug; 113(2):50-5. PubMed ID: 5538194
[No Abstract] [Full Text] [Related]
38. Association of the long-acting thyroid stimulator protector with the immunoglobulin G fraction of serum from patients with thyrotoxicosis.
Dirmikis SM; Justice SK; Munro DS
Biochim Biophys Acta; 1975 Jan; 379(1):239-46. PubMed ID: 1115798
[TBL] [Abstract][Full Text] [Related]
39. Thyroid carcinoma and concurrent hyperthyroidism: a study of ten patients.
Hancock BW; Bing RF; Dirmikis SM; Munro DS; Neal FE
Cancer; 1977 Jan; 39(1):298-302. PubMed ID: 832245
[TBL] [Abstract][Full Text] [Related]
40. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
